Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant human growth hormone

B Wise, B Case

    ANNA Journal
    |February 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Recombinant human growth hormone (rhGH) therapy improves growth velocity in children with end-stage renal disease (ESRD). This intervention may positively impact their psychological well-being by improving height.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of specialist rehabilitation services on hospital length of stay and associated costs.

    The European journal of health economics : HEPAC : health economics in prevention and care·2017
    Same author

    Using alternative forage species to reduce emissions of the greenhouse gas nitrous oxide from cattle urine deposited onto soil.

    The Science of the total environment·2017
    Same author

    Evaluation of Clinical Metrology Instrument in Dogs with Osteoarthritis.

    Journal of veterinary internal medicine·2016
    Same author

    Imaging of neurosarcoidosis: common, uncommon, and rare.

    Clinical radiology·2015
    Same author

    Nitrous oxide emission factors for urine and dung from sheep fed either fresh forage rape (Brassica napus L.) or fresh perennial ryegrass (Lolium perenne L.).

    Animal : an international journal of animal bioscience·2014
    Same author

    A qualitative study of women's preferences for treatment of pelvic floor disorders.

    BJOG : an international journal of obstetrics and gynaecology·2010
    Same journal

    Preserving the art of nephrology nursing.

    ANNA journal·2000
    Same journal

    Categorizing the response to Epoetin alfa therapy. Case study of the anemic patient.

    ANNA journal·2000
    Same journal

    Improving adequacy of dialysis: using in-series dialyzers.

    ANNA journal·2000
    Same journal

    Putting the pleasure back into eating for the elderly on a maintenance hemodialysis diet!

    ANNA journal·2000
    Same journal

    Does iron cause bacterial infections in patients with end stage renal disease?

    ANNA journal·2000
    Same journal

    Effects of psychosocial education on adaptation in elderly hemodialysis patients.

    ANNA journal·2000
    See all related articles

    Area of Science:

    • Pediatric Nephrology
    • Endocrinology
    • Growth Disorders

    Background:

    • Children with end-stage renal disease (ESRD) often experience significant growth delays.
    • Recombinant human growth hormone (rhGH) is a therapeutic option for various growth issues.

    Purpose of the Study:

    • To evaluate the efficacy of rhGH replacement therapy in children with ESRD.
    • To assess the impact of rhGH on growth velocity and potential psychological benefits.

    Main Methods:

    • Utilized rhGH as a replacement therapy in pediatric patients with ESRD.
    • Monitored growth velocity as a primary outcome measure.

    Main Results:

    • rhGH therapy resulted in improved growth velocity in children with ESRD.

    Related Experiment Videos

  • Enhanced height may contribute to improved psychological well-being.

    • Conclusions:

    • rhGH is an effective treatment for growth delay in children with ESRD.
    • Improved physical growth through rhGH therapy can positively influence psychosocial adjustment.